Literature DB >> 3348778

Alkyl-linked diglycerides inhibit protein kinase C activation by diacylglycerols.

L W Daniel1, G W Small, J D Schmitt, C J Marasco, K Ishaq, C Piantadosi.   

Abstract

Alkylacylglycerols are synthesized when choline-phospholipids are degraded by a phospholipase C. This class of compounds has been shown to have biological activities; however, the mechanism of action is unknown. A series of alkyl-linked diglycerides were synthesized and tested for activity in an in vitro assay for protein kinase C. When protein kinase C activity was stimulated with the synthetic diacylglyceride analog 1-oleoyl-2-acetyl-sn-glycerol, the addition of alkyl glycerides caused a concentration-dependent inhibition of protein kinase C activity. Comparison of the protein kinase C inhibition by this series of 1-O-alkyl-2-acyl analogs revealed that both saturated and unsaturated long-chain groups in position 1 were effective and that dietherglycerols with short-chain moieties in position 2 were also effective. It is concluded from these studies that the biological activity of alkyl-linked glycerides may be expressed through protein kinase C inhibition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348778     DOI: 10.1016/0006-291x(88)90592-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  The regulation and cellular functions of phosphatidylcholine hydrolysis.

Authors:  M M Billah; J C Anthes
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

Review 2.  Group XV phospholipase A₂, a lysosomal phospholipase A₂.

Authors:  James A Shayman; Robert Kelly; Jessica Kollmeyer; Yongqun He; Akira Abe
Journal:  Prog Lipid Res       Date:  2010-11-11       Impact factor: 16.195

3.  Inhibitory effect of 1-O (2 methoxy) hexadecyl glycerol and phenylbutyrate on the malignant properties of human prostate cancer cells.

Authors:  S Reynolds; H Cederberg; S Chakrabarty
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania.

Authors:  T B McNeely; G Rosen; M V Londner; S J Turco
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

5.  Chemoproteomic discovery of AADACL1 as a regulator of human platelet activation.

Authors:  Stephen P Holly; Jae Won Chang; Weiwei Li; Sherry Niessen; Ryan M Phillips; Raymond Piatt; Justin L Black; Matthew C Smith; Yacine Boulaftali; Andrew S Weyrich; Wolfgang Bergmeier; Benjamin F Cravatt; Leslie V Parise
Journal:  Chem Biol       Date:  2013-08-29

6.  Structural analysis of a glycosylphosphatidylinositol glycolipid of Leishmania donovani.

Authors:  D Sevlever; P Påhlsson; G Rosen; B Nilsson; M V Londner
Journal:  Glycoconj J       Date:  1991-08       Impact factor: 2.916

7.  Ether lipid metabolism by AADACL1 regulates platelet function and thrombosis.

Authors:  Stephen P Holly; Nidhi Gera; Putianqi Wang; Alexander Wilson; Ziqiang Guan; Ling Lin; Brian Cooley; Hammodah R Alfar; Ruchi G Patil; Raymond Piatt; Tina M Leisner; Wolfgang Bergmeier; Rinku Majumder; Leslie V Parise
Journal:  Blood Adv       Date:  2019-11-26

8.  Synthesis and biological evaluation of ether-linked derivatives of phosphatidylinositol.

Authors:  K S Ishaq; M Capobianco; C Piantadosi; A Noseda; L W Daniel; E J Modest
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

9.  Diacylglycerol synthesis de novo from glucose by pancreatic islets isolated from rats and humans.

Authors:  B A Wolf; R A Easom; M L McDaniel; J Turk
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

10.  The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells.

Authors:  F Mollinedo; C Gajate; M Modolell
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.